XML 49 R30.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2018
Income Tax Disclosure [Abstract]  
Schedule of Income Tax Expense (Benefit)

From our TRS and our foreign operations, income tax expense (benefit) were as follows (in thousands):

 

 

 

For the Years Ended December 31,

 

 

 

2018

 

 

2017

 

 

2016

 

Current income tax (benefit) expense:

 

 

 

 

 

 

 

 

 

 

 

 

Domestic

 

$

(125

)

 

$

(41

)

 

$

42

 

Foreign

 

 

3,294

 

 

 

3,062

 

 

 

1,856

 

 

 

 

3,169

 

 

 

3,021

 

 

 

1,898

 

Deferred income tax (benefit) expense:

 

 

 

 

 

 

 

 

 

 

 

 

Domestic

 

 

(3,713

)

 

 

(233

)

 

 

147

 

Foreign

 

 

1,471

 

 

 

(107

)

 

 

(8,875

)

 

 

 

(2,242

)

 

 

(340

)

 

 

(8,728

)

Income tax expense (benefit)

 

$

927

 

 

$

2,681

 

 

$

(6,830

)

Summary of Reconciliation of the Income Tax Expense (Benefit) at the Statutory Income Tax Rate and the Effective Tax Rate for Income before Income Taxes

A reconciliation of the income tax expense (benefit) at the statutory income tax rate and the effective tax rate for income before income taxes for the years ended December 31, 2018, 2017, and 2016 is as follows (in thousands):

 

 

 

2018

 

 

2017

 

 

2016

 

Income before income tax

 

$

1,019,404

 

 

$

293,919

 

 

$

219,107

 

Income tax at the U.S. statutory federal rate (21% in 2018 and 35% in

   2017 and 2016)

 

 

214,075

 

 

 

102,872

 

 

 

76,687

 

Increase (decrease) resulting from:

 

 

 

 

 

 

 

 

 

 

 

 

Foreign rate differential

 

 

(2,643

)

 

 

(2,326

)

 

 

1,434

 

State income taxes, net of federal benefit

 

 

379

 

 

 

 

 

 

66

 

U.S. earnings not subject to federal income tax

 

 

(208,472

)

 

 

(98,026

)

 

 

(84,927

)

Equity investments

 

 

(46

)

 

 

3,293

 

 

 

4,297

 

Change in valuation allowance

 

 

(2,668

)

 

 

(5,391

)

 

 

(6,104

)

Other items, net

 

 

302

 

 

 

2,259

 

 

 

1,717

 

Total income tax expense (benefit)

 

$

927

 

 

$

2,681

 

 

$

(6,830

)

Schedule of Deferred Tax Assets and Liabilities

At December 31, 2018 and 2017, components of our deferred tax assets and liabilities were as follows (in thousands):

 

 

 

2018

 

 

2017

 

Deferred tax assets:

 

 

 

 

 

 

 

 

Operating loss and interest deduction carry forwards

 

$

21,984

 

 

$

24,580

 

Other

 

 

277

 

 

 

504

 

Total deferred tax assets

 

 

22,261

 

 

 

25,084

 

Valuation allowance

 

 

(3,444

)

 

 

(11,101

)

Total net deferred tax assets

 

$

18,817

 

 

$

13,983

 

Deferred tax liabilities:

 

 

 

 

 

 

 

 

Property and equipment

 

$

(12,359

)

 

$

(4,336

)

Net unbilled revenue

 

 

(1,633

)

 

 

(6,113

)

Partnership investments

 

 

 

 

 

(2,099

)

Other

 

 

(300

)

 

 

(1,320

)

Total deferred tax liabilities

 

 

(14,292

)

 

 

(13,868

)

Net deferred tax asset (liability)

 

$

4,525

 

 

$

115

 

Schedule of Per Share Distributions to Stockholders

A schedule of per share distributions we paid and reported to our stockholders is set forth in the following:

 

 

 

For the Years Ended December 31,

 

 

 

2018

 

 

2017

 

 

2016

 

Common share distribution

 

$

0.990000

 

 

$

0.950000

 

 

$

0.900000

 

Ordinary income

 

 

0.438792

 

 

 

0.655535

 

 

 

0.619368

 

Capital gains(1)

 

 

0.551208

 

 

 

0.021022

 

 

 

0.102552

 

Unrecaptured Sec. 1250 gain

 

 

0.132280

 

 

 

0.004647

 

 

 

0.045432

 

Section 19A Dividends

 

 

0.438792

 

 

 

 

 

 

 

Return of capital

 

 

 

 

 

0.273443

 

 

 

0.178080

 

 

(1)

Capital gains include unrecaptured Sec. 1250 gains.